Search

Salt Lake City-based molecular diagnostics startup Lineagen said today that it has raised $3.5M in a Series C round of funding. The funding was led by Signal Peak Ventures and Sanderling Ventures, and also included PrairieGold Venture Partners, Mesa Verde Venture Partners, Archipel Capital, University Venture Fund, Hatteras Funds, and KickStart Seed Fund. The company said the funding included $2.6M in equity plus $0.9M in convertible senior subordinated notes. The deal also included the conversion of $12.6M in outstanding promissory notes into shares of Series B preferred stock. Lineagen is developing genetic testing, counseling, and development screening services for identifying genetically linked disorders, particularly in the area of screening for autism.
posted on Wednesday, December 18, 2013 (Link to more information)

Related companies:
Lineagen

Related stories:
> Lineagen Lands $19.8M For Molecular Diagnostics Effort
> LineaGen Raises $5.8M For Molecular Diagnostics Firm
> Lineagen Raises $5M
> Lineagen Seeks $15M
> Lineagen Aims At $15M Series B

---

Techrockies.com Home